TCIM
PRAH

TIAA CREF Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

TIAA CREF Investment Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$23.8M Buy
215,652
+8,449
+4% +$883K 0.02% 648
2018
Q4 		$19.1M Buy
207,203
+9
+0% +$911 0.02% 668
2018
Q3 		$22.8M Sell
207,194
-3,215
-2% -$335K 0.01% 692
2018
Q2 		$19.6M Sell
210,409
-35,865
-15% -$3.09M 0.01% 756
2018
Q1 		$20.4M Sell
246,274
-7,747
-3% -$688K 0.01% 755
2017
Q4 		$23.1M Buy
254,021
+25,177
+11% +$2.09M 0.02% 724
2017
Q3 		$17.4M Buy
228,844
+19,195
+9% +$1.45M 0.01% 824
2017
Q2 		$15.7M Buy
209,649
+57,594
+38% +$3.99M 0.01% 874
2017
Q1 		$9.92M Buy
152,055
+11,690
+8% +$689K 0.01% 1129
2016
Q4 		$7.74M Buy
140,365
+10,173
+8% +$558K 0.01% 1303
2016
Q3 		$7.36K Buy
130,192
+7,093
+6% +$348K ﹤0.01% 1326
2016
Q2 		$5.14M Buy
123,099
+28,789
+31% +$1.33M ﹤0.01% 1520
2016
Q1 		$4.03M Buy
94,310
+8,487
+10% +$359K ﹤0.01% 1650
2015
Q4 		$3.88M Sell
85,823
-31,382
-27% -$1.32M ﹤0.01% 1733
2015
Q3 		$4.55M Sell
117,205
-29,556
-20% -$1.18M ﹤0.01% 1597
2015
Q2 		$5.33M Buy
146,761
+27,076
+23% +$856K ﹤0.01% 1634
2015
Q1 		$3.45M Buy
119,685
+93,019
+349% +$2.59M ﹤0.01% 1877
2014
Q4 		$646K Buy
+26,666
New +$601K ﹤0.01% 2873

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

TIAA CREF Investment Management's PRAH Position: Q1 2019 in Review

TIAA CREF Investment Management increased its PRA Health Sciences, Inc. (PRAH) stake by 4.1% in Q1 2019, buying an estimated $883K and bringing the position to 215,652 shares worth $23.8M. The position accounts for 0.02% of the portfolio, ranked #648.

TIAA CREF Investment Management first reported a position in PRAH in Q4 2014 and has held it in 18 quarters since. 354 funds tracked by Wall St. Rank hold PRAH as of Q1 2019.

  • TIAA CREF Investment Management held 215,652 shares of PRA Health Sciences, Inc. worth $23.8M as of Q1 2019.
  • TIAA CREF Investment Management bought 8,449 PRA Health Sciences, Inc. shares in Q1 2019, an estimated $883K.
  • PRA Health Sciences, Inc. made up 0.02% of TIAA CREF Investment Management's portfolio in Q1 2019, its #648 holding.
  • TIAA CREF Investment Management first reported a position in PRA Health Sciences, Inc. in Q4 2014 and has held it in 18 quarters since.
  • 354 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.